BrentLWoodMDPhD

PubMed

• Maturational dyssynchrony in benign B-cell precursors following lymphocyte depleting chemotherapy: A potential pitfall for B-lymphoblastic leukemia minimal/measurable ...
  Alexander Placek, Brian Lockhart, Karin P Miller, Gerald B Wertheim, Shannon L Maude, Brent L Wood, Alexandra E Kovach> ;Cytometry. Part B, Clinical Cytometry. 2024 Mar 1
• 4 citations
  Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study.
  Meenakshi Devidas, Ryan J Summers, Zhiguo Chen, Patrick A Zweidler-McKay, Naomi J Winick, William L Carroll, Mignon L Loh, Stephen P Hunger, Kimberly P Dunsmore, Stuar...> ;Blood. 2023 Dec 14
• Updates on lymphoblastic leukemia/lymphoma classification and minimal/measurable residual disease analysis.
  Alexandra E Kovach, Brent L Wood> ;Seminars in Diagnostic Pathology. 2023 Nov 1
• 2 citations
  Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748.
  Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, Ayoma D Attygalle, Iguaracyra Barreto de Oliveira Araujo, Emilio Berti, Govind Bhagat, Anita Maria Borges, Dani...> ;Leukemia. 2023 Sep 1
• 7 citations
  Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia.
  Laura W Dillon, Jake Higgins, Hassan Nasif, Megan Othus, Lan Beppu, Thomas H Smith, Elizabeth Schmidt, Charles C Valentine Iii, Jesse J Salk, Brent L Wood, Harry P Erb...> ;Haematologica. 2024 Feb 1
• 6 citations
  Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia.
  Zhenhua Li, Ti-Cheng Chang, Jacob J Junco, Meenakshi Devidas, Yizhen Li, Wenjian Yang, Xin Huang, Dale J Hedges, Zhongshan Cheng, Mary Shago, Andrew J Carroll, Nyla A ...> ;Blood. 2023 Jul 13
• 11 citations
  γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, ...
  Andrew J Cowan, Margot J Pont, Blythe D Sather, Cameron J Turtle, Brian G Till, Edward N Libby 3rd, David G Coffey, Sherilyn A Tuazon, Brent Wood, Ted Gooley, Vicky Q ...> ;The Lancet. Oncology. 2023 Jul 1
• 8 citations
  Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group report.
  Nathan P Gossai, Meenakshi Devidas, Zhiguo Chen, Brent L Wood, Patrick A Zweidler-McKay, Karen R Rabin, Mignon L Loh, Elizabeth A Raetz, Naomi J Winick, Michael J Burk...> ;Blood. 2023 Apr 13
• 10 citations
  Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia.
  Anjali S Advani, Anna Moseley, Kristen M O'Dwyer, Brent L Wood, Jae Park, Matthew Wieduwilt, Deepa Jeyakumar, George Yaghmour, Ehab L Atallah, Aaron T Gerds, Susan M O...> ;Blood Advances. 2023 Apr 11
• Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia.
  Laura W Dillon, Jake Higgins, Hassan Nasif, Megan Othus, Lan Beppu, Thomas H Smith, Elizabeth Schmidt, Charles C Valentine 3rd, Jesse J Salk, Brent L Wood, Harry P Erb...> ;Medrxiv. 2023 Mar 27
• 1 citations
  Prognostic impact of pretreatment immunoglobulin clonal composition in pediatric B-lymphoblastic leukemia.
  Lik Wee Lee, Meenakshi Devidas, Yunfeng Dai, Karen R Rabin, Sumit Gupta, Mignon L Loh, Ilan R Kirsch, Brent Wood, Rachel E Rau, Fries, C.> ;Haematologica. 2023 Mar 1
• 84 citations
  The genomic landscape of pediatric acute lymphoblastic leukemia.
  Samuel W Brady, Kathryn G Roberts, Zhaohui Gu, Lei Shi, Stanley Pounds, Deqing Pei, Cheng Cheng, Yunfeng Dai, Meenakshi Devidas, Chunxu Qu, Ashley N Hill, Debbie Payne...> ;Nature Genetics. 2022 Sep 1
• 11 citations
  Relative impact of residual cytogenetic abnormalities and flow cytometric measurable residual disease on outcome after allogeneic hematopoietic cell transplantation in...
  Corentin Orvain, Jacob A Wilson, Min Fang, Brenda M Sandmaier, Eduardo Rodríguez-Arbolí, Brent L Wood, Megan Othus, Frederick R Appelbaum, Roland B Walter> ;Haematologica. 2023 Feb 1
• 5 citations
  Inhibition of the Sec61 translocon overcomes cytokine-induced glucocorticoid resistance in T-cell acute lymphoblastic leukaemia.
  Lauren K Meyer, Cristina Delgado-Martin, Phillip P Sharp, Benjamin J Huang, Dustin McMinn, Tiffaney L Vincent, Theresa Ryan, Terzah M Horton, Brent L Wood, David T Tea...> ;British Journal of Haematology. 2022 Jul 1
• 1043 citations
  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
  Khoury, J., Solary, E., Abla, O., Akkari, Y., Alaggio, R., Apperley, J., Bejar, R., Berti, E., Busque, L., Chan, J., Chen, W., Chen, X., Chng, W., Choi, J., Colmenero,...> ;Leukemia. 2022 Jul 1
• 40 citations
  Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma.
  David T Teachey, Meenakshi Devidas, Brent L Wood, Zhiguo Chen, Robert J Hayashi, Michelle L Hermiston, Robert D Annett, J Hunter Archer, Barbara L Asselin, Keith J Aug...> ;Journal of Clinical Oncology. 2022 Jul 1
• 897 citations
  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.
  Alaggio, R., Amador, C., Anagnostopoulos, I., Attygalle, A., Araujo, I., Berti, E., Bhagat, G., Borges, A., Boyer, D., Calaminici, M., Chadburn, A., Chan, J., Cheuk, W...> ;Leukemia. 2022 Jul 1
• 6 citations
  JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemia.
  Kimberly Bodaar, Natsuko Yamagata, Anais Barthe, Jack Landrigan, Triona Ni Chonghaile, Melissa Burns, Kristen E Stevenson, Meenakshi Devidas, Mignon L Loh, Stephen P H...> ;Leukemia. 2022 Jun 1
• 29 citations
  SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphobla...
  Anjali S Advani, Anna Moseley, Kristen M O'Dwyer, Brent L Wood, Min Fang, Matthew J Wieduwilt, Ibrahim Aldoss, Jae H Park, Rebecca B Klisovic, Maria R Baer, Wendy Stoc...> ;Journal of Clinical Oncology. 2022 May 10
• 3 citations
  CD22low/Bcl-2high expression identifies poor response to inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia.
  Astrid Wintering, Kenichi Ishiyama, Stanley Tamaki, Courtney Tamaki, Joshua Fandel, Lingyun Ji, Brent L Wood, Nirali N Shah, Constance M Yuan, Maureen M O'Brien, Migno...> ;Blood Advances. 2023 Jan 24
• 9 citations
  Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report.
  Sumit Gupta, David T Teachey, Zhiguo Chen, Karen R Rabin, Kimberly P Dunsmore, Eric C Larsen, Kelly W Maloney, Leonard A Mattano Jr, Stuart S Winter, Andrew J Carroll,...> ;Cancer. 2022 May 1
• 48 citations
  Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.
  Adam J Lamble, Regina M Myers, Agne Taraseviciute, Samuel John, Bonnie Yates, Seth M Steinberg, Jennifer Sheppard, Alexandra E Kovach, Brent Wood, Michael J Borowitz, ...> ;Blood Advances. 2023 Feb 28
• 33 citations
  Naive T-Cell Depletion to Prevent Chronic Graft-Versus-Host Disease.
  Marie Bleakley, Alison Sehgal, Stuart Seropian, Melinda A Biernacki, Elizabeth F Krakow, Ann Dahlberg, Heather Persinger, Barbara Hilzinger, Paul J Martin, Paul A Carp...> ;Journal of Clinical Oncology. 2022 Apr 10
• 6 citations
  Measurable Residual Disease Detection in B-Acute Lymphoblastic Leukemia: The Children's Oncology Group (COG) Method.
  Michael J Borowitz, Brent L Wood, Michael Keeney, Benjamin D Hedley> ;Current Protocols. 2022 Mar 1
• 27 citations
  Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party.
  Jesse M Tettero, Sylvie Freeman, Veit Buecklein, Adriano Venditti, Luca Maurillo, Wolfgang Kern, Roland B Walter, Brent L Wood, Christophe Roumier, Jan Philippé, Barba...> ;Hemasphere. 2022 Jan 1
• Join now to see all

Journal Articles

• Second Cycle Remission Achievement with 7+3 and Survival in Adults with Newly Diagnosed Acute Myeloid Leukemia: Analysis of Recent SWOG Trials  
  Brent L Wood, Roland B Walter, John E Godwin, James K Weick, Elihu H Estey, Derek L Stirewalt, Frederick R Appelbaum, Nature
• Genomic and Outcome Analyses of Ph-like ALL in NCI Standard-Risk Patients: A Report from the Children's Oncology Group  
  Michael J Borowitz, Nyla A Heerema, Brent L Wood, Elizabeth A Raetz, Stephen P Hunger, Andrew J Carroll, Mignon L Loh, Cheryl L Willman, Kelly W Maloney, Blood
• Genomic Analyses Identify Recurrent MEF2D Fusions in Acute Lymphoblastic Leukaemia  
  Michael Borowitz, Hagop M Kantarjian, Cheryl L Willman, Stephen P Hunger, Selina M Luger, Clara D Bloomfield, Brent Wood, Jerald P Radich, Marina Konopleva, Stephen J ..., Nature

Abstracts/Posters

• Outcome in Adolescent and Young Adult (AYA) Patients Compared to Younger Patients Treated for High-Risk B-Lymphoblastic Leukemia (HR B-ALL): Report from the ChildrenÍs...
  Brent L Wood, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Myelodysplastic Syndrome with Excess Blasts and Secondary Acute Myeloid Leukemia: Same Disease with Different Blast Count
  Brent L Wood, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Comprehensive Evaluation and Validation of a Next-Generation Sequencing Assay for Minimal Residual Disease Detection in T-Lymphoblastic Leukemia/Lymphoma
  Brent L Wood, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Excellent Outcomes with Reduced Frequency of Vincristine and Dexamethasone Pulses in Children with National Cancer Institute (NCI) Standard-Risk B Acute Lymphoblastic ...
  Brent L Wood, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Comparative Analysis of Total Body Irradiation (TBI)-Based and Non-TBI-Based Myeloablative Conditioning for Acute Myeloid Leukemia in Remission with and without Measur...
  Brent L Wood, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Efficacy and Safety of Fully Human Bcma CAR T Cells in Combination with a Gamma Secretase Inhibitor to Increase Bcma Surface Expression in Patients with Relapsed or Re...
  Brent L Wood, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Development and Performance of Risk Stratification Models for AML Patients Utilizing ELN-2017 Guidelines and Additional Prognostic Factors: A SWOG Report
  Brent L Wood, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• The Genomic Landscape of Childhood Acute Lymphoblastic Leukemia
  Brent L Wood, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Comparison of Acute Myeloid Leukemia Measurable Residual Disease Detection By Flow Cytometry in Peripheral Blood and Bone Marrow
  Brent L Wood, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Response to Bcma CAR-T Cells Correlates with Pretreatment Target Antigen Density and Is Improved By Small Molecule Inhibition of Gamma Secretase
  Brent L Wood, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Triple Intrathecal Therapy (Methotrexate/Hydrocortisone/Cytarabine) Does Not Improve Disease-Free Survival Versus Intrathecal Methotrexate Alone in Children with High ... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Results of SWOG 1318: A Phase 2 Trial of Blinatumomab Followed By Pomp (Prednisone, Vincristine, Methotrexate, 6-Mercaptopurine) Maintenance in Elderly Patients with N... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018